Biohaven Pharma (BHVN) Tops Q4 EPS by 28c

Biohaven Pharma (NYSE: BHVN) reported Q4 EPS of ($0.90), $0.28 better than the analyst estimate of ($1.18).

For earnings history and earnings-related data on Biohaven Pharma (BHVN) click here.

You May Also Be Interested In

• IDT Corp. (IDT) Tops Q3 EPS by 2c; offer guidance
• Us Says Israel, Lebanon Agree To Implement Ceasefire - Bloomberg
• After-Hours Stock Movers: AVGO, CRWD, FIVE, AI, TLYS, NTSK,